Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Leukemia, Myeloid, Acute 78Myelodysplastic Syndromes 75Precursor Cell Lymphoblastic Leukemia-Lymphoma 70Leukemia, Lymphocytic, Chronic, B-Cell 58Leukemia 55Hodgkin Disease 55Lymphoma, Non-Hodgkin 54Lymphoma 48Multiple Myeloma 45Myeloproliferative Disorders 41Lymphoma, Follicular 40Graft vs Host Disease 38Lymphoma, Mantle-Cell 36Lymphoma, Large B-Cell, Diffuse 36Leukemia, Myelomonocytic, Chronic 36Lymphoma, B-Cell, Marginal Zone 35Leukemia, Myeloid, Accelerated Phase 34Leukemia, Myelogenous, Chronic, BCR-ABL Positive 33Congenital Abnormalities 33Burkitt Lymphoma 33Leukemia, Myeloid, Chronic-Phase 29Primary Myelofibrosis 28Hematologic Neoplasms 28Neoplasms, Plasma Cell 24Lymphoma, Large-Cell, Immunoblastic 24Blast Crisis 24Waldenstrom Macroglobulinemia 20Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 19Myelodysplastic-Myeloproliferative Diseases 18Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17

Interventions

Bevacizumab 69Sorafenib 66lenvatinib 59durvalumab 38sintilimab 33Nivolumab 32tislelizumab 28atezolizumab 28pembrolizumab 27Oxaliplatin 26tremelimumab 23apatinib 22Fluorouracil 22Radiosurgery 20regorafenib 19camrelizumab 18Doxorubicin 18cabozantinib 16Leucovorin 16Capecitabine 16Radiotherapy 14Folfox protocol 14donafenib 13Gemcitabine 13Cisplatin 12toripalimab 11Erlotinib Hydrochloride 10spartalizumab 8anlotinib 8Neoadjuvant Therapy 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Hepatocellular × Tacrolimus × Clear all
NCT02702960 2018-06-15

Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn
Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Carcinoma, Hepatocellular

NCT01374750 2016-06-01

Sirolimus

Seoul National University Hospital

Phase 2 Completed
45 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡